EPLR 2/2020
The second issue of the European Pharmaceutical Law Review in the 2020 is now available. The issue features an article on the price control of publicly financed medicinal products in Slovenia as well case notes on the recent Avastin decision and the judgment concerning the legitimacy of patent settlement agreements within the EU competition law framework. The issue also features our special series on the regulatory response to the Covid – 19 pandemic:
- The Road to a Vaccine for COVID-19: Regulatory and Policy Infrastructure, Incentives and Obstacles
- COVID-19, Vaccines, Brexit and Vaccine Damage Claims
- Responses to Medical Device Shortage: An Italian Perspective
- A Commentary on Contact Proximity Tracing Apps in the Context of the EU Legal Framework for Medical Devices
As well as updates on the most recent court decisions and the latest policy developments, the issue also features a review of Matthias Herdegen’s book on the international law of biotechnology.
View the whole table of content of EPLR 2/2020: Here
The European Pharmaceutical Law Review (EPLR) is seeking original research papers for a special issue on global pharmaceutical law and policy.
Please see for details our Special Call for Papers